Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
abv-1505 save search
ABVC BioPharma ABV-1505 ADHD Phase IIa Results Presented at 2023 APSARD Conference
Published: 2023-01-19 (Crawled : 14:20) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 3.29%
H: 5.06%
C: -1.25%
abv-1505 biopharma conference adhd results
FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer
Published: 2023-01-05 (Crawled : 15:00) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 106.45%
H: 46.09%
C: -16.41%
abv-1519 treatment fda biopharma lung cancer study submission
Thermo Fisher Scientific Introduces All-in-One AAV Production System for Scalable Gene Therapy Workflows and Commercial Applications
Published: 2022-11-16 (Crawled : 14:00) - biospace.com/
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
system commercial therapy
ABVC BioPharma Receives Notice of Allowance from US Patent and Trademark Office for ABV-1504 Used to Treat Major Depressive Disorder (MDD)
Published: 2022-11-07 (Crawled : 18:00) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 13.03%
H: 0.05%
C: -9.47%
abv-1504 biopharma patent major depressive disorder
Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites
Published: 2021-10-27 (Crawled : 14:00) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: -1.2%
H: 2.85%
C: -2.03%
adhd
Complete AAV Production System Enables Scalable Gene Therapy Workflows
Published: 2021-09-20 (Crawled : 12:00) - prnewswire.com
TMO | News | $544.78 0.6% 0.0% 1.7M
|
Health Technology
|
| O: -0.5%
H: 1.6%
C: -0.42%
gene therapy therapy aav9 gene therapies system
ABVC BioPharma Completes Site Selection for ABV-1505 ADHD Phase II Part 2 Clinical Study
Published: 2021-09-13 (Crawled : 16:00) - biospace.com/
ABVC | $0.9899 -5.72% -6.07% 160K
|
Wholesale Trade
|
| O: 4.05%
H: 0.53%
C: -10.18%
biopharma adhd
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.